Format

Send to

Choose Destination
JAMA. 2018 Jul 17;320(3):301-303. doi: 10.1001/jama.2018.7619.

Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation.

Author information

1
Yale School of Medicine, New Haven, Connecticut.
2
Collaboration for Research Integrity and Transparency, Yale University, New Haven, Connecticut.
3
Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
PMID:
30027239
DOI:
10.1001/jama.2018.7619
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center